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ABSTRACT 
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. The virus 
is mainly transmitted through droplets generated when an infected person coughs, sneezes, or exhales. The 
firsthand reason for COVID 19 is upper respiratory dysfunction which allows the entry of viruses in the 
respiratory system and leads to severe problems in the human body. Thus, Bitter taste receptor, TAS2Rs on 
human airway smooth muscle (ASM) found in the respiratory system can play a big role in providing immunity 
against COVID-19. Activation of TAS2Rs by bitter agonists activates host defense pathways through calcium 
signaling. Cytokines storms is the another reason for COVID -19 that can be prevented by TAS2Rs because it 
can regulate natural killer cell-mediated cytotoxicity, chemokine signaling pathways, T cell receptor signaling 
pathways, TNF signaling pathways, and others. Since, we propose to utilize caffeine, the bitter agonists to 
stimulate the TAS2Rs, activating host defense mechanisms and also suppressing the cytokine storms due to its 
anti-inflammatory action, altogether leading to an ameliorated effects of COVID-19. 
Keywords: COVID-19, Taste Receptor (TAS2Rs), caffeine 
1. Introduction 
The current outbreak of COVID-19 caused by 2019-coronavirus has led to tremendous loss to 
mankind and hence declared pandemic. Human coronaviruses (hCoVs) can be divided into low 
pathogenic and highly pathogenic corona viruses. The low pathogenic CoVs infect the upper 
respiratory tract whereas highly pathogenic hCoVs shows severe pneumonia-like symptoms which are 
often associated with rapid virus replication, massive inflammatory cell infiltration and elevated 
pro-inflammatory cytokine/chemokine responses further resulting in Acute Lung Injury (ALI), and 
Acute Respiratory Distress Syndrome (ARDS) [1]. The morbidity, mortality, and transmissibility of 
this novel coronavirus remain unharmonious [2][3]. Due to the unavailability of effective anti-viral 
therapies; affordable, safe, and effective medicines are urgently required for COVID- 19. 
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2. Active role of TAS2Rs in airway cells 
Very recently, it was concluded that 2019-nCoV replicates efficiently in the upper respiratory tract. 
Airway Smooth Muscle Cells (ASMCs), a structural component of the walls of all the airways within 
the bronchial tree which controls the diameter of the pulmonary airways by contraction/relaxation. 
Hypercontraction of ASMCs leads to airway constriction and obstruction. In humans, ASMC’s 
G-protein coupled receptor (GPCR) family named type 2 taste receptors (TAS2Rs), are critical role 
players in host defense pathways [4][5]. Previously, TAS2Rs, whose ligands are bitter substances, 
were thought to be expressed only on the tongue. However, recent studies demonstrated that they are 
highly expressed in extra-oral tissues as well [4]. This indicates that TAS2Rs might have functions 
other than bitter taste perception in the biological system. The most dominant subtypes of TAS2Rs in 
humans are TAS2R10; 14 and 31 and their activation by bitter tastants induces significant 
broncho-dilatory effects. Together, bitter agonists are considered as a novel class of bronchodilators in 
the treatment of obstructive airway diseases [5].  
Apart from this, it has been found that TAS2R10 is involved not only in controlling several infectious 
diseases caused by bacteria, viruses, and parasites, but also in various types of cancers which suggests 
that TAS2R10 may be a key trigger of host defense pathways. Many researchers have arrived at a 
similar consensus [6]. Altogether, these findings suggest that TAS2Rs may robustly regulate human 
innate immunity and trigger host defenses to control the infection [4]. Therefore, TAS2R10 can be a 
useful target model to identify the function of bitter taste receptor agonists. And thus, we propose to 
utilize bitter agonists to fight COVID-19. 
3. Efficacy of caffeine 
Caffeine, a widely accepted bitter-tasting compound having methyl-xanthine alkaloid is tremendously 
attracting the attention due to its variety of physiological and pharmacological activities. It can be one 
of the effective agonists to trigger the host defense pathway by targeting TAS2Rs. To date, the upper 
respiratory tract is the most important door to be closed for fighting against preventing this deadly 
disease. Therefore, we believe that activating bitter receptors can be an effective approach to prevent 
the deadly virus from efficiently replicating in the upper respiratory tract. Other studies have shown 
that TAS2Rs can also activate the robust calcium-dependent secretion of Anti- Microbial Peptides 
(AMPs), including β-defensin-1 and 2, in the epithelial cells of the respiratory tract. AMPs can 
vigorously block the interaction between a virus and its receptor. Therefore, interpretation of the 
complete signaling pathways linking TAS2R receptors on ASM cells and further their activation 
through IP3 receptors and Ca2+sensitivity may be beneficial in the identification of novel protectant 
bronchodilators functioning through the TAS2R receptors [7]. Caffeine is long known to be beneficial 
in preventing and treating apnea and bronchopulmonary dysplasia in newborns.  
Also, a cytokine storm is another key event causing the death of patients infected with coronavirus [1]. 
Thus, inhibiting overactive immune responses can also be very important in these fatalities from 
preventing cytokine storms. Thankfully, Caffeine also acts as an anti-inflammatory agent by 
non-selectively inhibiting the phosphodiesterases (PDEs). Briefly, the Inhibition of PDEs raises the 
intracellular concentration of cyclic AMP (cAMP), which downstream activates protein kinase A and 
inhibits leukotriene synthesis. This leads to reduced inflammation and enhanced innate immunity. It 
also raises cyclic guanosine monophosphate levels in the body, thus relaxing smooth muscle, dilating 
airways, and lowering pulmonary arterial pressure[8]. Taken together, Available data suggest that 
caffeine remains the mainstay in the prevention of respiratory health problems. 
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Apart from this, A report suggests the antiviral activities of caffeine by inhibiting viral protein 
synthesis [9] and suppressing plaque formation by interfering with the cell-to-cell transmission in 
certain viruses such as poliovirus, influenza virus, HSV-1, vaccinia virus, Newcastle Disease Virus 
(NDV), Japanese encephalitis virus and adenovirus. Similar to TNF or octyl gallate, Caffeine 
preferentially accelerates the cytopathic effects (CPE) and the death of virus-infected cells by 
selective apoptosis.  
Surprisingly, Caffeine can also interfere with virus multiplication after viral DNA replication, 
probably at the formation of progeny infectious virus step, because similar results were observed 
when the multiplication of HSV-1 was inhibited by ammonium chloride or Brefeldin A during the 
formation of infectious progeny virus after viral DNA replication and nucleocapsid formation [10]. 
4. Conclusion  
So, are we skipping a conclusive link? Can the reason be our thought process which is stopping us to 
believe that the prevention of this pandemic cannot be that simple or is it that we have not explored 
this corner of the house. To conclude, we would like to attract the attention of our fellow researchers 
working globally to emphasize onto these possibilities and suggest the population, some more 
beneficial and easily accessible products that may minimize the deterioration, the Covid-19 could do, 
thereby, minimizing the loss to mankind. Just to add, the intake should be managed keeping all the 
other medical conditions of the subject in mind. Preferentially, a low but regular intake is what we 
would greatly recommend. 
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